Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

2025-05-07 14:18:22 ET

Seres Therapeutics, Inc. (MCRB)

Q1 2025 Earnings Call

May 7, 2025 08:30 ET

Company Participants

Carlo Tanzi - Investor Relations

Eric Shaff - President and Chief Executive Officer

Marella Thorell - Chief Financial Officer

Matthew Henn - Chief Scientific Officer

Terri Young - Chief Commercial and Strategy Officer

Dennis Walling - Senior Vice President, Clinical Development

Conference Call Participants

Caroline Pötsch-Hennig - JPMorgan

Joseph Thome - TD Cowen

John Newman - Canaccord

Presentation

Operator

Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Seres Therapeutics First Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Dr. Carlo Tanzi of Investor Relations. You may begin.

Carlo Tanzi

Thank you and good morning. Our press release with the company’s first quarter 2025 financial results and business updates became available at 7 a.m. Eastern Time this morning and can be found on the Investors and News section of the company’s website. The company has also posted an updated corporate presentation to the website....

Read the full article on Seeking Alpha

For further details see: